CA Stock MarketDetailed Quotes
DTC Defence Therapeutics Inc
- 0.880
- +0.030+3.53%
15min DelayMarket Closed Jul 12 15:19 ET
40.07MMarket Cap-4631P/E (TTM)
0.890High0.850Low124.61KVolume0.850Open0.850Pre Close106.71KTurnover3.04052wk High0.29%Turnover Ratio45.54MShares0.68052wk Low-0.19EPS TTM37.85MFloat Cap8.150Historical HighLossP/E (Static)43.01MShs Float0.680Historical Low-0.2EPS LYR4.71%Amplitude--Dividend TTM-17.60P/B1Lot Size--Div YieldTTM
About Defence Therapeutics Inc Company
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.
Company Profile
SymbolDTC
Company NameDefence Therapeutics Inc
Founded2017
MarketCNQ
Fiscal Year Ends06-30
Address200 Burrard Street Suite 1680
CityVancouver
CountryCAN
Zip CodeV6C3L6
Phone+1 514 947-2272
Company Executives
- Name
- Position
- Salary
- Simon Beaudoin
- CTSO and Accum Co-Founder
- --
- Sebastien Plouffe
- CEO and Director
- --
- Joseph Meagher
- CFO and Director
- --
- Raimar Lobenberg
- Chairman of the Board
- --
- Sarkis Meterissian
- Director
- --
- Moutih Rafei
- VP Research and Development and Director
- --
Heat List
CA
Overall
Symbol
Latest Price
%Chg